Magnetic susceptibility matched fluid for neuroimaging assessed in histology and stereology: A pilot study
Journal of Neuropathology & Experimental Neurology · 2026
DOI: 10.1093/jnen/nlaf165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2026. Verfasst von Emma W Rosenblum und 7 weiteren Autor:innen. Beteiligte Einrichtung: Athinoula A. Martinos Center, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, United States. Hauptthemen laut MEDLINE: Brain, Magnetic Resonance Imaging, Fluorocarbons, Neuroimaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute Health grants, NIA NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Ex vivo MRI allows for ultra-high resolution image acquisition and valuable validation when combined with histology. Postmortem brain samples may undergo long scan times without motion artifacts. Perfluoropolyethers such as Fomblin have become a popular choice of immersion liquid for their “proton free” appearance and their ability to eliminate susceptibility artifacts from the tissue-air interface but the effect of Fomblin on downstream histology experiments has not been previously studied. We exposed rat brain samples to Fomblin (n = 4) versus a control group (n = 4). Samples underwent histochemical (Nissl) and immunohistochemical staining for NeuN to assess neurons and background staining. The optical fractionator method was applied to assess total neuron counts and tissue thickness. Samples from the Fomblin group showed consistent NeuN and Nissl staining when compared to the control group. The staining color, evenness, and neuron visualization appeared unaffected with no background staining. The total neuron counts, and tissue thickness showed only slight differences in absolute numbers between groups with insufficient evidence to conclude the distribution of total neuron number or tissue thickness differed by group. These data suggest that Fomblin may not negatively impact histochemical staining, immunohistochemistry, or total neuron counts in the short term.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Athinoula A. Martinos Center, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, United States.
- RIKEN-MIT Laboratory for Neural Circuit Genetics at the Picower Institute for Learning and Memory, Cambridge, MA, United States.
- Department of Brain and Cognitive Sciences, MIT, Cambridge, MA, United States.
- Howard Hughes Medical Institute, MIT, Cambridge, MA, United States.
- Department of Radiology, Massachusetts General Hospital, Boston, MA, United States.
- Harvard Medical School, Harvard University, Boston, MA, United States.
ORCID-Profile: Emma W Rosenblum, Jean C Augustinack
Förderung
- National Institute Health grants
- NIA NIH HHS
- NINDS NIH HHS
- National Institute On Aging
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Rosenblum, E. W., Takeuchi, D., Chadha, S., Mercaldo, N. D., Williams, E. M., Roy, J., Ackerman, J. L., & Augustinack, J. C. (2026). Magnetic susceptibility matched fluid for neuroimaging assessed in histology and stereology: A pilot study. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlaf165
Vancouver
Rosenblum EW, Takeuchi D, Chadha S, Mercaldo ND, Williams EM, Roy J, et al. Magnetic susceptibility matched fluid for neuroimaging assessed in histology and stereology: A pilot study. Journal of Neuropathology & Experimental Neurology. 2026. doi:10.1093/jnen/nlaf165
BibTeX
@article{Rosenblum2026,
author = {Rosenblum, Emma W and Takeuchi, Daigo and Chadha, Smriti and Mercaldo, Nathaniel D and Williams, Emily M and Roy, Jessica and Ackerman, Jerome L and Augustinack, Jean C},
title = {Magnetic susceptibility matched fluid for neuroimaging assessed in histology and stereology: A pilot study},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2026},
doi = {10.1093/jnen/nlaf165}
}
EUVIMED